Free Trial

agilon health (NYSE:AGL) Stock Price Up 3.8% - Still a Buy?

agilon health logo with Medical background

agilon health, inc. (NYSE:AGL - Get Free Report) shares were up 3.8% on Wednesday . The company traded as high as $2.33 and last traded at $2.32. Approximately 1,137,301 shares changed hands during trading, a decline of 77% from the average daily volume of 4,935,184 shares. The stock had previously closed at $2.23.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on AGL shares. Sanford C. Bernstein raised shares of agilon health from a "market perform" rating to an "outperform" rating and raised their price objective for the stock from $3.30 to $8.50 in a research note on Tuesday, April 8th. TD Cowen raised their price objective on shares of agilon health from $3.50 to $6.00 and gave the stock a "hold" rating in a research note on Tuesday, April 15th. Wells Fargo & Company dropped their price objective on shares of agilon health from $6.00 to $5.00 and set an "overweight" rating for the company in a research note on Tuesday, May 13th. The Goldman Sachs Group raised their price objective on shares of agilon health from $2.50 to $5.00 and gave the stock a "neutral" rating in a research note on Thursday, May 8th. Finally, Barclays raised their price objective on shares of agilon health from $2.00 to $3.00 and gave the stock an "underweight" rating in a research note on Thursday, May 8th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, agilon health currently has a consensus rating of "Hold" and an average price target of $4.79.

Check Out Our Latest Stock Analysis on AGL

agilon health Stock Performance

The company has a market cap of $918.97 million, a price-to-earnings ratio of -2.36 and a beta of 0.38. The stock's fifty day simple moving average is $3.79 and its two-hundred day simple moving average is $3.18. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.

agilon health (NYSE:AGL - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, beating analysts' consensus estimates of ($0.01) by $0.04. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.50 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. agilon health's revenue for the quarter was down 4.5% on a year-over-year basis. During the same quarter last year, the business earned ($0.02) EPS. Equities research analysts anticipate that agilon health, inc. will post -0.59 EPS for the current year.

Hedge Funds Weigh In On agilon health

Hedge funds have recently made changes to their positions in the stock. Ieq Capital LLC acquired a new position in shares of agilon health in the 4th quarter valued at $26,000. Signaturefd LLC lifted its holdings in shares of agilon health by 143.0% during the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after acquiring an additional 8,467 shares in the last quarter. Humankind Investments LLC acquired a new position in shares of agilon health during the 4th quarter valued at $30,000. Raymond James Financial Inc. acquired a new position in shares of agilon health during the 4th quarter valued at $33,000. Finally, Cerity Partners LLC acquired a new position in shares of agilon health during the 4th quarter valued at $34,000.

About agilon health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Further Reading

Should You Invest $1,000 in agilon health Right Now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines